Benjamin H Han1,2, Scott Sherman1,2,3, Pia M Mauro4, Silvia S Martins4, James Rotenberg1, Joseph J Palamar2,3. 1. Department of Medicine, Division of Geriatric Medicine and Palliative Care, New York University School of Medicine, New York, NY, USA. 2. Center for Drug Use and HIV Research, New York University College of Nursing, New York, NY, USA. 3. Department of Population Health, New York University School of Medicine, New York, NY, USA. 4. Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.
Abstract
BACKGROUND AND AIMS: The ageing US population is providing an unprecedented population of older adults who use recreational drugs. We aimed to estimate the trends in the prevalence of past-year use of cannabis, describe the patterns and attitudes and determine correlates of cannabis use by adults age 50 years and older. DESIGN: Secondary analysis of the National Survey on Drug Use and Health survey from 2006 to 2013, a cross-sectional survey given to a nationally representative probability sample of populations living in US households. SETTING: USA. PARTICIPANTS: A total of 47 140 survey respondents aged ≥ 50 years. MEASURES: Estimates and trends of past-year use of cannabis. FINDINGS: The prevalence of past-year cannabis use among adults aged ≥ 50 increased significantly from 2006/07 to 2012/13, with a 57.8% relative increase for adults aged 50-64 (linear trend P < 0.001) and a 250% relative increase for those aged ≥ 65 (linear trend P = 0.002). When combining data from 2006 to 2013, 6.9% of older cannabis users met criteria for cannabis abuse or dependence, and the majority of the sample reported perceiving no risk or slight risk associated with monthly cannabis use (85.3%) or weekly use (79%). Past-year users were more likely to be younger, male, non-Hispanic, not have multiple chronic conditions and use tobacco, alcohol or other drugs compared with non-past-year cannabis users. CONCLUSIONS: The prevalence of cannabis use has increased significantly in recent years among US adults aged ≥ 50 years.
BACKGROUND AND AIMS: The ageing US population is providing an unprecedented population of older adults who use recreational drugs. We aimed to estimate the trends in the prevalence of past-year use of cannabis, describe the patterns and attitudes and determine correlates of cannabis use by adults age 50 years and older. DESIGN: Secondary analysis of the National Survey on Drug Use and Health survey from 2006 to 2013, a cross-sectional survey given to a nationally representative probability sample of populations living in US households. SETTING: USA. PARTICIPANTS: A total of 47 140 survey respondents aged ≥ 50 years. MEASURES: Estimates and trends of past-year use of cannabis. FINDINGS: The prevalence of past-year cannabis use among adults aged ≥ 50 increased significantly from 2006/07 to 2012/13, with a 57.8% relative increase for adults aged 50-64 (linear trend P < 0.001) and a 250% relative increase for those aged ≥ 65 (linear trend P = 0.002). When combining data from 2006 to 2013, 6.9% of older cannabis users met criteria for cannabis abuse or dependence, and the majority of the sample reported perceiving no risk or slight risk associated with monthly cannabis use (85.3%) or weekly use (79%). Past-year users were more likely to be younger, male, non-Hispanic, not have multiple chronic conditions and use tobacco, alcohol or other drugs compared with non-past-year cannabis users. CONCLUSIONS: The prevalence of cannabis use has increased significantly in recent years among US adults aged ≥ 50 years.
Authors: Madeline H Meier; Avshalom Caspi; Antony Ambler; HonaLee Harrington; Renate Houts; Richard S E Keefe; Kay McDonald; Aimee Ward; Richie Poulton; Terrie E Moffitt Journal: Proc Natl Acad Sci U S A Date: 2012-08-27 Impact factor: 11.205
Authors: Deborah S Hasin; Tulshi D Saha; Bradley T Kerridge; Risë B Goldstein; S Patricia Chou; Haitao Zhang; Jeesun Jung; Roger P Pickering; W June Ruan; Sharon M Smith; Boji Huang; Bridget F Grant Journal: JAMA Psychiatry Date: 2015-12 Impact factor: 21.596
Authors: Reto Auer; Eric Vittinghoff; Kristine Yaffe; Arnaud Künzi; Stefan G Kertesz; Deborah A Levine; Emiliano Albanese; Rachel A Whitmer; David R Jacobs; Stephen Sidney; M Maria Glymour; Mark J Pletcher Journal: JAMA Intern Med Date: 2016-03 Impact factor: 44.409
Authors: Christopher M Jones; Joseph Logan; R Matthew Gladden; Michele K Bohm Journal: MMWR Morb Mortal Wkly Rep Date: 2015-07-10 Impact factor: 17.586
Authors: Pia M Mauro; Hannah Carliner; Qiana L Brown; Deborah S Hasin; Dvora Shmulewitz; Reanne Rahim-Juwel; Aaron L Sarvet; Melanie M Wall; Silvia S Martins Journal: J Stud Alcohol Drugs Date: 2018-05 Impact factor: 2.582
Authors: Julie Bobitt; Sara H Qualls; Melissa Schuchman; Robert Wickersham; Hillary D Lum; Kanika Arora; Gary Milavetz; Brian Kaskie Journal: Drugs Aging Date: 2019-07 Impact factor: 3.923
Authors: Christopher P Salas-Wright; Michael G Vaughn; Lenise A Cummings-Vaughn; Katherine J Holzer; Erik J Nelson; Millan AbiNader; Sehun Oh Journal: Drug Alcohol Depend Date: 2016-12-14 Impact factor: 4.492
Authors: Eduardo Romano; Pedro A Torres-Saavedra; Hilda I Calderón Cartagena; Robert B Voas; Anthony Ramírez Journal: J Stud Alcohol Drugs Date: 2018-07 Impact factor: 2.582